PPARγ Agonist Pioglitazone Reverses Memory Impairment and Biochemical Changes in a Mouse Model of Type 2 Diabetes Mellitus
Work
Year: 2012
Type: article
Abstract: SUMMARY Aims: Pioglitazone, known as a peroxisome proliferator‐activated receptor γ (PPARγ) agonist, is used to treat type 2 diabetes mellitus (T2DM). T2DM has been associated with reduced performance... more
Source: CNS Neuroscience & Therapeutics
Institutions China Pharmaceutical University, Second Hospital of Anhui Medical University, Anhui Medical University
Cites: 40
Cited by: 92
Related to: 10
FWCI: 5.07
Citation percentile (by year/subfield): 92.6
Subfield: Clinical Biochemistry
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $2,530